About Arsenal Biosciences
Arsenal Biosciences is a private company based in South San Francisco, California. It has reported $579,159,214 raised in three offerings on Form D since September 2022.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 9, 2024 | Sep 4, 2024 | $325,352,578fully sold | 26 | $12.5M | EquityRule 506(b) | Form D ↗ |
| Feb 10, 2022 | Sep 9, 2022 | $220,806,682of $230.8M target | 17 | $12.9M | EquityRule 506(b) | Form D ↗ |
| Dec 14, 2020 | Sep 9, 2022 | $32,999,954fully sold | 9 | $3.6M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $579,159,214 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Arsenal Biosciences's Form D filed Sep 4, 2024.
MF
Matthew Fust
Director
VB
Valentin Barsan
Director
SP
Sean Parker
Director
BB
Brook Byers
Director
JA
James Ahlers
Executive officer
KD
Kenneth Drazan
Executive officer and director
IP
Irene Pleasure
Secretary
BS
Beth Seidenberg
Director
Earlier filings also listed Margaret Nibbi (chief legal officer, last listed Sep 2022).